Visit COVID-19 resources

[Skip to Content]

New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy – (Eye Journal)

21 June 2019

This news item is available to RCOphth members only, please log in below to access.

Members Login